Login / Signup

Omalizumab may facilitate drug desensitization in patients failing standard protocols.

Hatice Betul Gemici KaraaslanEsra Karabag YilmazRuveyda GulmezNur CanpolatAyça KiykimHaluk Cezmi Cokugras
Published in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2022)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • patient reported outcomes
  • adverse drug